Table 1.
IFN-γ spot-forming cells per 106 mononuclear cellsa |
||||
---|---|---|---|---|
Monkey | MHC class I alleles | Acute SHIVb PBMC | Necropsy PBMC | Necropsy spleen |
26817 | A08 | 76 | 60 | 65 |
32357 | — c | 146 | 30 | 225 |
32365 | A11 | Negative | Negative | Negative |
29372 | — | 83 | Negative | Negative |
30886 | B01 | 101 | Negative | 35 |
25907 | B01 | 66 | Negative | 55 |
30616 | — | 210 | 70 | Negative |
30851 | A01 | 270 | 165 | 45 |
30811 | B01 | NDd | 65 | Negative |
IFN-γ, interferon γ; MHC, major histocompatibility complex; PBMC, peripheral blood mononuclear cell; SHIV, simian–human immunodeficiency virus; SIV, simian immunodeficiency virus.
A sample was considered positive if the number of IFN-γ-secreting cells per well exceeded 50 cells per 1×106 mononuclear cells and if the number of positive IFN-γ spot-forming cells (SFC) was greater than the mean number of SFC found in the medium-only wells plus 2 s.d.. Data are reported as the number of IFN-γ SFC per 1×106 PBMC. For reporting purposes, the background number of IFN-γ SFC observed in medium-only wells was subtracted from the number of IFN-γ SFC of SIV peptide-stimulated wells.
Eight to nine weeks post-SHIV89.6 immunization.
MHC class I loci and alleles were typed by PCR. A dash (—) indicates no known alleles.
ND indicates that a sample was missing or results were not interpretable.